🥇 First rule of investing? Know when to save! Up to 55% off Investing Pro before BLACK FRIDAYCLAIM SALE

Genocea Biosciences Inc (GNCAQ)

OTC Markets
Currency in USD
0.000001
0.000000(0.00%)
Closed
GNCAQ Scorecard
Full Analysis
Stock generally trades with high price volatility
Trading near 52-week Low
Fair Value
Day's Range
0.0000010.000001
52 wk Range
0.0000010.000200
Prev. Close
0.000001
Open
0.000001
Day's Range
0.000001-0.000001
52 wk Range
0.000001-0.0002
Volume
550
Average Volume (3m)
1,268
1-Year Change
-99%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
GNCAQ Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins
Show more

Genocea Bio Company Profile

Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products include GEN-011, an adoptive T cell therapy, which is in Phase 1/2a clinical trials for the treatment of solid tumors; and GEN-009, a neoantigen vaccine candidate, which is in Phase 1/2a clinical trials that delivers adjuvanted synthetic long peptides spanning ATLAS-identified anti-tumor neoantigens. The company was incorporated in 2006 and is based in Cambridge, Massachusetts. On July 5, 2022, Genocea Biosciences, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Massachusetts. The plan was later approved as Chapter 11 liquidation on May 11, 2023.

Compare GNCAQ to Peers and Sector

Metrics to compare
GNCAQ
Peers
Sector
Relationship
P/E Ratio
0.0x−3.3x−0.6x
PEG Ratio
0.000.270.00
Price/Book
0.0x2.9x2.6x
Price / LTM Sales
0.0x30.2x3.2x
Upside (Analyst Target)
0.0%137.4%44.1%
Fair Value Upside
Unlock1.2%6.2%Unlock

FAQ

What Is the Genocea Bio (GNCAQ) Stock Price Today?

The Genocea Bio stock price today is 0.000001.

What Stock Exchange Does Genocea Bio Trade On?

Genocea Bio is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Genocea Bio?

The stock symbol for Genocea Bio is "GNCAQ."

What Is the Genocea Bio Market Cap?

As of today, Genocea Bio market cap is 58.78null.

What is Genocea Bio Earnings Per Share?

The Genocea Bio EPS is -0.533.

What Is the Next Genocea Bio Earnings Date?

Genocea Bio will release its next earnings report on 10 Nov 2024.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.